- Home
- HCM vs NVG Comparison
HCM vs NVG Comparison
Compare HCM & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- NVG
- Stock Information
- Founded
- HCM 2000
- NVG 1999
- Country
- HCM Hong Kong
- NVG United States
- Employees
- HCM N/A
- NVG N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- NVG Investment Managers
- Sector
- HCM Health Care
- NVG Finance
- Exchange
- HCM Nasdaq
- NVG Nasdaq
- Market Cap
- HCM 2.3B
- NVG 2.6B
- IPO Year
- HCM N/A
- NVG N/A
- Fundamental
- Price
- HCM $13.52
- NVG $12.62
- Analyst Decision
- HCM Hold
- NVG
- Analyst Count
- HCM 1
- NVG 0
- Target Price
- HCM $19.00
- NVG N/A
- AVG Volume (30 Days)
- HCM 85.0K
- NVG 568.8K
- Earning Date
- HCM 02-26-2025
- NVG 01-01-0001
- Dividend Yield
- HCM N/A
- NVG 4.65%
- EPS Growth
- HCM N/A
- NVG N/A
- EPS
- HCM N/A
- NVG N/A
- Revenue
- HCM $610,806,000.00
- NVG N/A
- Revenue This Year
- HCM N/A
- NVG N/A
- Revenue Next Year
- HCM $18.76
- NVG N/A
- P/E Ratio
- HCM N/A
- NVG N/A
- Revenue Growth
- HCM N/A
- NVG N/A
- 52 Week Low
- HCM $13.00
- NVG $9.68
- 52 Week High
- HCM $21.92
- NVG $12.21
- Technical
- Relative Strength Index (RSI)
- HCM 40.71
- NVG 57.98
- Support Level
- HCM $13.10
- NVG $12.36
- Resistance Level
- HCM $13.92
- NVG $12.53
- Average True Range (ATR)
- HCM 0.38
- NVG 0.13
- MACD
- HCM 0.02
- NVG 0.04
- Stochastic Oscillator
- HCM 37.96
- NVG 81.52
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.